Intarcia Therapeutics Stock

intarcia.comHealthcareFunding to Date: $961.46MM

Intarcia is a biotech company dedicated to redesigning the treatment, prevention and experience of chronic disease.

Register for Details

For more details on financing and valuation for Intarcia Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Intarcia Therapeutics.

Register Today

Team

Management Team

Paul Feldman, Ph.D.
Head of Discovery and Translational Medicine
David Spellman
Chief Business Officer and Chief Financial Officer
Thomas Alessi, Ph.D.
Vice President, Development and Manufacturing
Fred Fiedorek, M.D.
Chief Medical Officer and Global Head of Regulatory Affairs
Raymond Keane
Chief Legal Officer
Thane Wettig
Chief Commercial Officer
Jay Smith
Chief Experience Officer
Kurt Graves
Chairman, President & Chief Executive Officer
Anders Vinther, Ph.D
Global Head of Technical Operations
James Brady
Vice President, Human Resources
Andrew Young, M.B., Ch.B. (M.D.), Ph.D.
Chief Scientific Officer

Board Members

Bryan Roberts, Ph.D.
Venrock
Patrick Conway, MD
Kurt Graves
Nancy Thornberry
Bob Kerrey
Gino Santini
Jay S. Skyler, MD, MACP
Jim Rosenthal

Other companies like Intarcia Therapeutics in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
 
 
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$4.26B
Sector
 
 

News

The Diabetic Therapeutic Market  report  provides valuable and unique information which is very  essential. Further it also covers key players,application and future market condition.This information is extremely useful information for new and growing  company to mark themself over the market Diabetic Therapeutic market to grow at a CAGR OF 7.55% during the period 2017-2021. This …
Tech companies are continuing to garner major venture capital investment in 2018. Here are the 25 most valuable VC-backed startups in the US.
Diabetic Therapeutic Market report evaluate the current opportunity and the future potential of the Diabetic Therapeutic market over the coming decade. Based on various parameters, Diabetic Therapeutic Market provides complete analysis of manufacturers, suppliers, distributors, traders, customers, major types and applications. “The global diabetic therapeutic market is growing at a high pace owing to the …